In 2009 PathXL made a bold move and announced that all our products would reside entirely in The Cloud. This introduced a new SaaS (Software as a Service) model to the Digital Pathology market. As a new player in the Digital Pathology market, this ability to serve products and digital slides wholly via the World Wide Web has become one of our USPs in this emerging market.
Digital Pathology was still in the early adoption phase in 2009, having been introduced in Education, EQA (External Quality Assurance) schemes and Research environments. There was yet to be any significant impact in the clinical world however, with pathologists resistant in swapping the microscope for the monitor. This resistance was mainly due to bandwidth issues, FDA clearance and limited access to scanners.
Adding The Cloud to the equation was met with many puzzled faces and a lot of questions. We have grouped some of the main early questions (Read More).
Source: PathXL (Eileen Reagan)